TherapeuticsMD, Inc. (NASDAQ:TXMD – Get Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 170,200 shares, a decline of 19.1% from the February 28th total of 210,500 shares. Based on an average daily trading volume, of 536,100 shares, the short-interest ratio is presently 0.3 days. Approximately 1.5% of the shares of the stock are sold short.
TherapeuticsMD Stock Performance
TherapeuticsMD stock opened at $0.93 on Tuesday. TherapeuticsMD has a 12 month low of $0.70 and a 12 month high of $2.44. The company’s fifty day simple moving average is $0.96 and its 200-day simple moving average is $1.24.
Analyst Ratings Changes
Separately, StockNews.com initiated coverage on shares of TherapeuticsMD in a research report on Tuesday, January 14th. They set a “hold” rating on the stock.
About TherapeuticsMD
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Recommended Stories
- Five stocks we like better than TherapeuticsMD
- 3 Stocks to Consider Buying in October
- Berkshire Hathaway Gains Defy Stock Market Slump
- Election Stocks: How Elections Affect the Stock Market
- Palantir Stock Builds Momentum on New Partnership
- Roth IRA Calculator: Calculate Your Potential Returns
- Tech Sell-Off Makes Microsoft Stock Look Like a Steal
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.
